Gene-based treatments are reshaping cancer care!
The #CancerGeneTherapy market will reach USD 32 Billion by 2035 at a 13.37% CAGR.
Leading the charge: 🔹@Novartis 🔹@Pfizer 🔹@Bluebirdbio
#GeneTherapy #Oncology #PrecisionMedicine #Biotech #HealthInnovation
www.einpresswire.com/article/8054....
The #CancerGeneTherapy market will reach USD 32 Billion by 2035 at a 13.37% CAGR.
Leading the charge: 🔹@Novartis 🔹@Pfizer 🔹@Bluebirdbio
#GeneTherapy #Oncology #PrecisionMedicine #Biotech #HealthInnovation
www.einpresswire.com/article/8054....
Cancer Gene Therapy Market Expected to Achieve a Strong 13.37% CAGR, to Reach USD 32.0 Billion by 2035
Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration.
www.einpresswire.com
October 13, 2025 at 7:29 AM
Gene-based treatments are reshaping cancer care!
The #CancerGeneTherapy market will reach USD 32 Billion by 2035 at a 13.37% CAGR.
Leading the charge: 🔹@Novartis 🔹@Pfizer 🔹@Bluebirdbio
#GeneTherapy #Oncology #PrecisionMedicine #Biotech #HealthInnovation
www.einpresswire.com/article/8054....
The #CancerGeneTherapy market will reach USD 32 Billion by 2035 at a 13.37% CAGR.
Leading the charge: 🔹@Novartis 🔹@Pfizer 🔹@Bluebirdbio
#GeneTherapy #Oncology #PrecisionMedicine #Biotech #HealthInnovation
www.einpresswire.com/article/8054....
🩸 The Sickle Cell Disease Market is expanding rapidly with advances in gene therapy & novel drugs.
Leading innovators:
🔹 @bluebirdbio
🔹 @VertexPharma
🔹 @Novartis
#SickleCell #RareDiseases #GeneTherapy #Biotech #HealthcareInnovation #MRFR
www.marketresearchfuture.com/reports/sick...
Leading innovators:
🔹 @bluebirdbio
🔹 @VertexPharma
🔹 @Novartis
#SickleCell #RareDiseases #GeneTherapy #Biotech #HealthcareInnovation #MRFR
www.marketresearchfuture.com/reports/sick...
Sickle Cell Disease Market Size, Trends, Growth Report 2035
Sickle Cell Disease Market 2025, Industry to reach USD 18.41 Billion, at a 13.52% CAGR by growing size, share, top company analysis, segments research, trends and forecast report 2025 to 2035
www.marketresearchfuture.com
October 10, 2025 at 11:58 AM
🩸 The Sickle Cell Disease Market is expanding rapidly with advances in gene therapy & novel drugs.
Leading innovators:
🔹 @bluebirdbio
🔹 @VertexPharma
🔹 @Novartis
#SickleCell #RareDiseases #GeneTherapy #Biotech #HealthcareInnovation #MRFR
www.marketresearchfuture.com/reports/sick...
Leading innovators:
🔹 @bluebirdbio
🔹 @VertexPharma
🔹 @Novartis
#SickleCell #RareDiseases #GeneTherapy #Biotech #HealthcareInnovation #MRFR
www.marketresearchfuture.com/reports/sick...
#Cellandgenetherapies #CGTs #CARTs #FDA #cellandgeneandtissuetherapies #CARTcelltherapies #AAV #autologousCARTtherapies #CD19 #BCMA #REMS #celltherapytechnologies #AnthonyNolan #CARTworkflow #Vertex #bluebirdbio #eXmoorPharma #CGTindustry #personalisedtreatment
pharmaphorum.com/deep-dive/ce...
pharmaphorum.com/deep-dive/ce...
Cell and gene therapies: Stagnation or maturation?
Despite questions around stagnation, experts argue that cell and gene therapies are evolving rapidly –driven by innovation in manufacturing, decentralisation, and targeted delivery. Nicole Raleigh gat...
pharmaphorum.com
September 3, 2025 at 11:59 AM